SCHEMBL69332

SCHEMBL69332

CCc1cc2c(C)cc(=O)oc2cc1OC

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 2/20 0.63
KDM4E B2RXH2 13/20 0.58
ALDH1A1 P00352 13/20 0.58
HPGD P15428 10/20 0.58
HSD17B10 Q99714 9/20 0.58
TSHR P16473 3/20 0.58
MAPT P10636 2/20 0.58
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
GAA P10253 4/20 0.54
GLA P06280 3/20 0.54
HSP90AA1 P07900 1/20 0.54
HSP90AB1 P08238 1/20 0.54
ALPG P10696 1/20 0.54
ALOX15 P16050 1/20 0.54
ALOX12 P18054 1/20 0.54
CASP1 P29466 1/20 0.54
CASP7 P55210 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
CYP1A2 P05177 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30819091 0.85 KDM4E (0.66) MCL1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL606446 0.85 KDM4E (0.66) MCL1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL11855333 0.83 MCL1 (0.54) MCL1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL8807762 0.79 KDM4E (0.70) MCL1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL591362 0.78 KDM4E (0.78) MCL1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL8359237 0.78 MCL1 (1.00) MCL1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL31282379 0.76 KDM4E (0.70) MCL1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL2183416 0.76 KDM4E (0.70) MCL1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL9367076 0.76 KDM4E (0.54) MCL1KDM4EALDH1A1HPGDHSD17B10
SCHEMBL4271081 0.75 KDM4E (0.50) MCL1KDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129087-B2 Block copolymer and substrate processing method CANON KABUSHIKI KAISHA (JP) 2012-03-06 US disclosed
CN-101256358-B Photosensitive compound, polyhydroxystyrene and novolac resin CANON KK 2011-06-22 CN disclosed
US-20090311637-A1 BLOCK COPOLYMER AND SUBSTRATE PROCESSING METHOD CANON KABUSHIKI KAISHA (JP) 2009-12-17 US disclosed
US-7615332-B2 Photosensitive compound, photosensitive composition, resist pattern forming method, and device production process CANON KABUSHIKI KAISHA (JP) 2009-11-10 US disclosed
US-20090233232-A1 PHOTOSENSITIVE COMPOUND, PHOTOSENSITIVE COMPOSITION, RESIST PATTERN FORMING METHOD, AND DEVICE PRODUCTION PROCESS CANON KABUSHIKI KAISHA (JP) 2009-09-17 US disclosed
CN-101256358-A Photosensitive compound, photosensitive composition, resist pattern forming method, and device production process CANON KK (JP) 2008-09-03 CN disclosed
EP-1956430-A1 Photosensitive compound, photosensitive composition, resist pattern forming method, and device production process Canon Kabushiki Kaisha (JP) 2008-08-13 EP disclosed
US-20080187864-A1 PHOTOSENSITIVE COMPOUND, PHOTOSENSITIVE COMPOSITION, RESIST PATTERN FORMING METHOD, AND DEVICE PRODUCTION PROCESS CANON KABUSHIKI KAISHA (JP) 2008-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233232-A1 PHOTOSENSITIVE COMPOUND, PHOTOSENSITIVE COMPOSITION, RESIST PATTERN FORMING METHOD, AND DEVICE PRODUCTION PROCESS FRG1, PAH, RER1 MCL1 3334/4885KDM4E 2439/4885ALDH1A1 1256/4885
US-20080187864-A1 PHOTOSENSITIVE COMPOUND, PHOTOSENSITIVE COMPOSITION, RESIST PATTERN FORMING METHOD, AND DEVICE PRODUCTION PROCESS FRG1, PAH, RER1 MCL1 3334/4885KDM4E 2439/4885ALDH1A1 1256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.